Some cancers occurred more frequently in people with multiple sclerosis (MS) than in others, a retrospective study in France ...

The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life ...

Triple negative breast cancer (TNBC) remains the most aggressive and deadly type of breast cancer, but new findings from cancer researchers at Brigham and Women’s Hospital, a founding member of the ...

The Foundation of the Consortium of Multiple Sclerosis Centers was gifted $100,000 by EMD Serono for its nursing scholarship ...

Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment 18F-Fluorodeoxyglucose ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its third-quarter 2024 sales and earnings conference call with institutional ...

Merck & Co. has picked up options on two Evaxion Biotech vaccine candidates, paying $3.2 million and dangling more than $1 billion in milestones for the chance to pick up preclinical prospects ...

EMD Serono, the healthcare business of Merck KGaA, Darmstadt, Germany in the U.S., works to transform lives by developing and delivering meaningful therapies, and working to truly understand and ...

Sept 25 (Reuters) - Merck (MRK.N), opens new tab said on Wednesday a combination of its experimental drug and blockbuster therapy Keytruda failed a late-stage trial testing it in previously ...